Clover Health Investments, Corp. (NASDAQ:CLOV – Get Free Report) fell 8.8% on Wednesday. The stock traded as low as $4.37 and last traded at $4.3150. Approximately 2,214,418 shares changed hands during mid-day trading, a decline of 62% from the average session volume of 5,781,903 shares. The stock had previously closed at $4.73.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on CLOV shares. Deutsche Bank initiated coverage on Clover Health Investments in a research note on Thursday, September 10th. They set a “buy” rating and a $6.00 price target for the company. Needham & Company LLC reiterated a “buy” rating on shares of Clover Health Investments in a research report on Thursday, November 5th. Canaccord Genuity Group boosted their target price on shares of Clover Health Investments from $4.20 to $5.50 and gave the company a “buy” rating in a research note on Tuesday, July 21st. Wall Street Zen lowered shares of Clover Health Investments from a “strong-buy” rating to a “buy” rating in a research note on Sunday, August 16th. Finally, UBS Group upped their price target on shares of Clover Health Investments from $5.00 to $5.50 and gave the stock a “neutral” rating in a report on Thursday, November 5th. Three investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $5.10.
View Our Latest Stock Analysis on CLOV
Clover Health Investments Stock Performance
The firm has a market capitalization of $2.34 billion, a PE ratio of 438.94 and a beta of 2.52. The company has a fifty day simple moving average of $4.63 and a two-hundred day simple moving average of $3.67.
Clover Health Investments (NASDAQ:CLOV – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.02. Clover Health Investments had a return on equity of 4.66% and a net margin of 0.45%. The firm had revenue of $759.30 million during the quarter, compared to the consensus estimate of $740.07 million. On average, equities analysts anticipate that Clover Health Investments, Corp. will post 0.06 earnings per share for the current fiscal year.
Insider Buying and Selling at Clover Health Investments
In other news, CEO Andrew Toy sold 62,176 shares of the stock in a transaction that occurred on Thursday, October 15th. The shares were sold at an average price of $4.68, for a total transaction of $290,983.68. Following the transaction, the chief executive officer directly owned 9,078,334 shares in the company, valued at approximately $42,486,603.12. This trade represents a 0.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Karen Soares sold 19,275 shares of Clover Health Investments stock in a transaction that occurred on Tuesday, October 20th. The shares were sold at an average price of $4.66, for a total transaction of $89,821.50. Following the transaction, the insider directly owned 1,573,423 shares in the company, valued at approximately $7,332,151.18. The trade was a 1.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 768,573 shares of company stock worth $3,462,479 over the last quarter. 23.51% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Clover Health Investments
Hedge funds have recently made changes to their positions in the stock. Public Employees Retirement System of Ohio purchased a new stake in shares of Clover Health Investments during the second quarter valued at about $42,000. Nykredit A S bought a new stake in shares of Clover Health Investments in the 2nd quarter valued at about $45,000. Ballew Advisors Inc purchased a new position in shares of Clover Health Investments in the 3rd quarter worth approximately $44,000. Nisa Investment Advisors LLC grew its position in shares of Clover Health Investments by 223.4% in the 3rd quarter. Nisa Investment Advisors LLC now owns 10,855 shares of the company’s stock worth $47,000 after buying an additional 7,498 shares during the last quarter. Finally, Allworth Financial LP grew its position in shares of Clover Health Investments by 200.7% in the 3rd quarter. Allworth Financial LP now owns 12,281 shares of the company’s stock worth $53,000 after buying an additional 8,197 shares during the last quarter. 19.77% of the stock is currently owned by hedge funds and other institutional investors.
About Clover Health Investments
Clover Health Investments is a U.S. healthcare company focused on Medicare. Its insurance business offers Medicare Advantage plans to eligible beneficiaries in select markets, combining medical coverage with support intended to help members access care. The company also developed the Clover Assistant, a technology platform that organizes patient information and provides clinicians with insights to support care decisions. Clover has described the platform as a way to help primary care providers identify health needs and coordinate care for people with complex conditions.
Read More
- Five stocks we like better than Clover Health Investments
- SpaceX’s Wild Ride Puts 2 Space Stocks and a Weekly-Payout ETF in Focus
- Palantir’s Political Controversy Is Hiding a Much Bigger Story
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.
